HUXLEY, Iowa--(BUSINESS WIRE)--Novozymes and Monsanto Company leaders this week highlighted how the companies’ BioAg Alliance is working to develop innovations for agriculture to boost productivity and further support the management of natural resources on the farm. The Alliance is expected to expand the research and commercialization of a new generation of microbials to help farmers meet the world’s demands for food and feed in a sustainable way. This year, the companies conducted research across 170,000 field trial plots in 70 locations throughout the United States, and the companies expect to more than double the number of research field plots next season.
“The early results from 2013 showed a lot of promise – we discovered several microbes that are demonstrating increased yield in corn and soybeans. We have expanded testing this year and believe we are on track to discover transformational microbial products farmers can add to their toolbox,” says Robb Fraley, executive vice president and chief technology officer, Monsanto.
Microbial-based solutions are derived from various microbes such as bacteria and fungi. The BioAg Alliance is researching the next generation of these solutions, and has already introduced two types of microbial products: inoculants products, which help plants take up nutrients, and biocontrol products, which help protect plants against pests, disease and weeds. The products can be utilized by farmers that grow broad acre crops such as corn and soy, and on fruits and vegetables.
“Microbials have a significant potential to transform modern agriculture and help meet growing global demand for food. The goal of The BioAg Alliance is to bring cutting-edge innovation in microbials to farmers, so they can produce more crops with fewer inputs,” says Thomas Videbæk, executive vice president for business development, Novozymes.
Microbials make up about two-thirds of the agricultural biologicals industry today, and build on the successful application of microbes in everything from personal healthcare to food processing and production. Today, microbials such as Rhizobium offer farmers ways to replace or complement traditional fertilizers, while Bacillus thuringiensis (Bt) sprays continue to be used in organic and conventional agriculture.
Novozymes and Monsanto formed The BioAg Alliance in February 2014. The Alliance brings together Novozymes’ capabilities for discovering, developing, and producing microbes and Monsanto’s discovery capabilities, field testing, and market reach.
To watch a brief video that explains microbials or for a graphic illustration of how microbials work, click here.
The BioAg Alliance pipeline will be featured in Monsanto’s tent during the Farm Progress Show, taking place in Boone, Iowa, August 26-28, 2014.
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries Novozymes creates tomorrow’s industrial biosolutions, improving its customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes’ bioinnovations increase industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for tomorrow’s ever-changing marketplace. Read more at www.novozymes.com.
About Monsanto Company
Monsanto is committed to bringing a broad range of solutions to help nourish our growing world. We produce a variety of seeds ranging from fruits and vegetables to key crops – such as corn, soybeans, and cotton – that help farmers produce abundant and nutritious food. We work to find sustainable agriculture solutions that help farmers conserve natural resources, use data to improve farming practices, use water and other important resources more efficiently, and protect their crops from pests and disease. Through programs and partnerships, we collaborate with farmers, researchers, nonprofit organizations, universities and others to help tackle some of the world’s biggest challenges. To learn more about Monsanto, our commitments and our more than 20,000 dedicated employees, please visit: discover.monsanto.com and monsanto.com. Follow our business on Twitter® at twitter.com/MonsantoCo, on the company blog, Beyond the Rows® at monsantoblog.com or subscribe to our News Release RSS Feed.
Monsanto Cautionary Statements Regarding Forward-Looking Information:
Certain statements contained in this release are “forward-looking statements,” such as statements concerning the company’s anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company’s actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company’s exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company’s research and development activities; the outcomes of major lawsuits and the previously-announced SEC investigation; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company’s estimates related to distribution inventory levels; the recent increases in and expected higher levels of indebtedness; the company’s ability to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company’s facilities; and other risks and factors detailed in the company’s most recent periodic report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.
Lee Quarles or John Combest, +1-314-694-6397
Johan Melchior, +45 30770690